W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL
|
Back to Search Results |
|
Catalog Number BXA085901J |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Unspecified Infection (1930)
|
Event Date 11/23/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.As it is unknown which device(s) may have contributed to the reported graft related infection and reintervention, two additional gore® viabahn® vbx balloon expandable endoprosthesis(vbx) devices have been included in this report: (b)(4) (udi/(b)(4) and (b)(4) (udi/(b)(4).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
On (b)(6) 2022, this patient underwent endovascular treatment of an aortoiliac occlusive disease/leriche syndrome using gore® viabahn® vbx balloon expandable endoprostheses (vbx).Three vbx devices were implanted, and the procedure was completed without any issue.On an unknown date in (b)(6) 2022, a graft infection was suspected.Reportedly, the patient had fever and back pain postoperatively, blood culture was performed twice and staphylococci was detected on both times.Furthermore, an abscess near the left iliopsoas muscle was observed on the ct imaging, and there was a suspicion of hydronephrosis due to compression of the ureter between the iliopsoas muscle and the abscess.On (b)(6) 2022, antimicrobial therapy was initiated and the fever improved.On (b)(6) 2022 ct guided percutaneous drainage was performed for the iliopsoas abscess.The patient tolerated the procedure.
|
|
Manufacturer Narrative
|
Updated h10/11 investigation findings and investigation conclusions.
|
|
Search Alerts/Recalls
|
|
|